《主动脉瓣狭窄合并冠状动脉疾病的评估和管理中国专家共识2025》编写组 ,杜俣,王志坚,张海波

• 1:首都医科大学附属北京安贞医院

摘要(Abstract)：

钙化性主动脉瓣狭窄（AS）和冠状动脉疾病（CAD）均是全球常见的心血管病，AS合并CAD患者在临床上亦很常见。对于拟行主动脉瓣置换术的AS合并CAD患者，如何评估心肌血运重建指征、选择心肌血运重建的方式和时机仍存在争议。为及时更新行业对AS合并CAD评估和管理的认识，本共识专家组通过系统文献回顾，结合自身实践深入讨论，更新了重度AS患者合并CAD的综合评估和管理策略。鉴于经导管主动脉瓣置入术（TAVI）在国内广泛应用，本共识同时介绍了TAVI术中冠状动脉闭塞风险的评估和预防方式，以及TAVI术后冠状动脉介入难点和应对策略。

关键词(KeyWords)： 主动脉瓣狭窄;冠状动脉疾病;主动脉瓣置换;心肌血运重建;专家共识

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 《主动脉瓣狭窄合并冠状动脉疾病的评估和管理中国专家共识2025》编写组 ,杜俣,王志坚,张海波

参考文献(References)：

• [1]Tarantini G,Tang G,Nai Fovino L,et al.Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation.A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery[J].EuroIntervention,2023,19(1):37-52.DOI:10.4244/EIJ-D-22-00958.
• [2]Carroll JD,Mack MJ,Vemulapalli S,et al.STS-ACC TVT registry of transcatheter aortic valve replacement[J].J Am Coll Cardiol,2020,76(21):2492-2516.DOI:10.1016/j.jacc.2020.09.595.
• [3]Stewart BF,Siscovick D,Lind BK,et al.Clinical factors associated with calcific aortic valve disease.Cardiovascular Health Study[J].J Am Coll Cardiol,1997,29(3):630-634.DOI:10.1016/s0735-1097(96)00563-3.
• [4]Holmes DR Jr,Nishimura RA,Grover FL,et al.Annual outcomes with transcatheter valve therapy:from the STS/ACC TVT registry[J].Ann Thorac Surg,2016,101(2):789-800.DOI:10.1016/j.athoracsur.2015.10.049.
• [5]D'Ascenzo F,Verardi R,Visconti M,et al.Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI:a meta-analysis of adjusted observational results[J].Euro Intervention,2018,14(11):e1169-e1177.DOI:10.4244/EIJ-D-18-00098.
• [6]Popma JJ,Adams DH,Reardon MJ,et al.Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery[J].J Am Coll Cardiol,2014,63(19):1972-1981.DOI:10.1016/j.jacc.2014.02.5 56.
• [7]Mack MJ,Leon MB,Thourani VH,et al.Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J].N Engl J Med,2019,380(18):1695-1705.DOI:10.1056/NEJMoa1814052.
• [8]Banovic M,Athithan L,McCann GP.Aortic stenosis an d diabetes mellitus:an ominous combination[J].Diab Vasc Dis Res,2019,16(4):310-323.DOI:10.1177/1479164118820657.
• [9]Thubrikar MJ,Deck JD,Aouad J,et al.Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve[J].Atherosclerosis,1985,55(3):299-311.DOI:10.1016/0021-9150(85)90108-x.
• [10]Di Gioia G,Bartunek J,Tesorio T,et al.Pathophysiology,diagnosis,and treatment of patients with concomitant severe aortic stenosis and coronary artery disease:a closer look to the unresolved perplexity[J].J Clin Med,2021,10(8):1617.DOI:10.3390/jcm10081617.
• [11]Pawade TA,Newby DE,Dweck MR.Calcification in aortic stenosis:the skeleton key[J].J Am Coll Cardiol,2015,66(5):561-577.DOI:10.1016/j.jacc.2015.05.066.
• [12]Lindman BR,Clavel MA,Mathieu P,et al.Calcific aortic steno sis[J].Nat Rev Dis Primers,2016,2:16006.DOI:10.1038/nrdp.2016.6.
• [13]Beach JM,Mihalj evic T,Svensson LG,et al.Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis[J].J Am Coll Cardiol,2013,61(8):837-848.DOI:10.1016/j.jacc.2012.10.049.
• [14] Dewey TM,Brown DL,Herbert MA,et al.Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation[J].Ann Thorac Surg,2010,89(3):758-767;discussion767.DOI:10.1016/j.athoracsur.2009.12.033.
• [15]Ussia GP,Barbanti M,Colombo A,et al.Impact of coronary arterydisease in elderly patients undergoing transcatheter aortic valve implantation:insight from the Italian CoreValve Registry[J].Int J Cardiol,2013,167(3):943-950.DOI:10.1016/j.ijcard.2012.03.089.
• [16]Khawaja MZ,Asrress KN,Haran H,et al.The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation(TAVI)using the Edwards bioprosthesis[J].Euro Intervention,2015,11(4):450-455.DOI:10.4244/EIJY14M05 09
• [17] Paradis JM,White JM,Généreux P,et al.Impact of coronary artery disease severity assessed with the SYNTAX score on outcomes following transcatheter aortic valve replacement[J].J Am Heart Assoc,2017,6(2):e005070.DOI:10.1161/JAHA.116.005070.
• [18]Lawton JS,Tamis-Holland JE,Bangalore S,et al.2021 ACC/AHA/SCAI guideline for coronary artery revascularization:executive summary:a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J].Circulation,2022,145(3):e4-e17.DOI:10.1161/CIR.0000000000001039.
• [19]Kodali SK,Moses JW.Coronary artery disease and aortic stenosis in the transcatheter aortic valve replacement era:old questions,new paradigms:the evolving role of percutaneous coronary intervention in the treatment of patients with aortic stenosis[J].Circulation,2012,125(8):975-977.DOI:10.1161/CIRCULATION AHA.111.087965.
• [20]Marwick TH,Torelli J,Harjai K,et al.Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography[J].J Am Coll Cardiol,1995,26(5):1180-1186.DOI:10.1016/0735-1097(96)81472-0.
• [21]Iung B.Interface between valve disease and ischaemic heart disease[J].Heart,2000,84(3):347-3 52.DOI:10.1136/heart.84.3.347.
• [22]Patsilinakos SP,Spanodimos S,Rontoyanni F,et al.Adeno sine stress myocardial perfusion tomographic imaging in patients with significant aortic steno sis[J].J Nucl Cardiol,2004,11(1):20-25.DOI:10.1016/j.nuclcard.2003.10.003.
• [23]Cremer PC,Khalaf S,Lou J,et al.Stress position emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement[J].J Nucl Cardiol,2014,21(5):1001-1010.DOI:10.1007/s12350-014-9928-y.
• [24]Phichap hop A,Sorajja P,Enriquez-Sarano M,et al.Feasibility of computed tomography as a gatekeeper for invasive angiography before TAVR:a pragmatic real-world experience[J].Circ Cardiovasc Interv,2025,18(8):e015181.DOI:10.1161/CIRCINTERVENTIONS.125.015181.
• [25]Michail M,Ihdayhid AR,Comella A,et al.Feasibility and validity of computed tomography-derived fractional flow reserve in patients with severe aortic stenosis:the CAST-FFR study[J].Circ Cardiovasc Interv,2021,14(1):e009586.DOI:10.1161/CIRCINTERVENTIONS.120.009586.
• [26]Hu F,Lai Q,Fang J,et al.The impact of transcatheter aortic valve replacement on changes of coronary computed tomographyderived fractional flow reserve[J].Ann Med,2024,56(1):2420860.DOI:10.1080/0785 3890.2024.2420860.
• [27] Si-Mohamed SA,Boccalini S,Lacombe H,et al.Coronary CT angiography with photon-counting CT:first-in-human results[J].Radiology,2022,303(2):303-313.DOI:10.1148/radiol.211780.
• [28]Burgstahler C,Kunze M,Gawaz MP,et al.Adenosine stress first pass perfusion for the detection of coronary artery disease in patients with aortic stenosis:a feasibility study[J].Int J Cardiovasc Imaging,2008,24(2):195-200.DOI:10.1007/s10554-007-9236-6.
• [29]Ahmad Y,G??tberg M,Cook C,et al.Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement:implications forclinical indices of coronary stenosis severity[J].JACC Cardiovasc Interv,2018,11(20):2019-2031.DOI:10.1016/j.jcin.2018.07.019.
• [30]Mejia-Renteria H,Nombela-Franco L,Paradis JM,et al.Angiographybased quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis[J].EuroIntervention,2020,16(4):e285-e292.DOI:10.4244/EIJ-D-19-01001.
• [31]Thalji NM,Suri RM,Daly RC,et al.The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery:implications for revascularization in the transcatheter era[J].J Thorac Cardiovasc Surg,2015,149(2):451-460.DOI:10.1016/j.jtcvs.2014.08.073.
• [32]Vahanian A,Beyersdorf F,Praz F,et al.2021 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J,2022,43(7):561-632.DOI:10.1093/eurheartj/ehab395.
• [33]Santana O,Pineda AM,Cortes-Bergoderi M,et al.Hybrid approach of percutaneous coronary intervention followed by minimally invasive valve operations[J].Ann Thorac Surg,2014,97(6):2049-205 5.DOI:10.1016/j.athoracsur.2014.02.039.
• [34]Byrne JG,Leacche M,Vaughan DE,et al.Hybrid cardiovascular procedures[J].JACC Cardiovasc Interv,2008,1(5):459-468.DOI:10.1016/j.jcin.2008.07.002.
• [35]Patterson T,Clayton T,Dodd M,et al.ACTIVATION(percutaneous coronary intervention prior to transcatheter aortic valve implantation):a randomized clinical trial[J].JACC Cardiovasc Interv,2021,14(18):1965-1974.DOI:10.10 16/j.jcin.2021.06.041.
• [36] Patel KP,Michail M,Treibel TA,et al.Coronary revascularization in patients undergoing aortic valve replacement for severe aortic stenosis[J].JACC Cardiovasc Interv,2021,14(19):2083-2096.DOI:10.1016/j.jcin.2021.07.058.
• [37]L??nborg J,Jabbari R,Sabbah M,et al.PCI in patients undergoing transcatheter aortic-valve implantation[J].N Engl J Med,2024,391(2 3):2189-2200.DOI:10.1056/NEJMoa2401513.
• [38]Praz F,Borger MA,Lanz J,et al.2025 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J,2025,46(44):463 5-4736.DOI:10.1093/eurheartj/ehaf194.
• [39]王志华,赵泽原,胡俊龙,等.完全经导管与外科主动脉瓣置换术治疗主动脉瓣狭窄合并冠心病的倾向性评分匹配研究[J].中国胸心血管外科临床杂志,2025,32(12):1708-1715.
• [40]Kedhi E,Hermanides RS,Dambrink JE,et al.TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease(TCW):an international,multicentre,prospective,open-label,non-inferiority,randomised controlled trial[J].Lancet,2025,404(10471):2593-2602.DOI:10.1016/s0140-6736(24)02100-7.
• [41]周政,张龙岩,杨剑,等.急诊经导管主动脉瓣置换术的疗效初探:一项多中心研究[J].中华心血管病杂志,2022,50(7):698-704.DOI:10.3760/cma.j.cn112148-20220601-00434.
• [42]Ramee S,Anwaruddin S,Kumar G,et al.The Rationale for performance of coronary angiography and stenting before transcatheter aortic valve replacement:from the Interventional Section Leadership Council of the American College of Cardiology[J].JACC Cardiovasc Interv,2016,9(23):2371-2375.DOI:10.1016/j.jcin.2016.09.024.
• [43]Faroux L,Campelo-Parada F,Munoz-Garcia E,et al.Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup pre-TAVR[J].JACC Cardiovasc Interv,2020,13(22):2601-2613.DOI:10.1016/j.jcin.2020.07.009.
• [44]Chakravarty T,Sharma R,Abramowitz Y,et al.Outcomes in patients with transcatheter aortic valve replacement and left main stenting:the TAVR-LM registry[J].J Am Coll Cardiol,2016,67(8):951-960.DOI:10.1016/j.jacc.2015.10.103.
• [45]Kirtane AJ,Doshi D,Leon MB,et al.Treatment of higherrisk patients with an indication for revascularization:evolution within the field of contemporary percutaneous coronary intervention[J].Circulatio n,2016,134(5):422-431.DOI:10.1161/CIRCULATIONAHA.116.022061.
• [46]Dvir D,Leipsic J,Blanke P,et al.Coronary obstruction in transcatheter aortic valve-in-valve implantation:preprocedural evaluation,device selection,protection,and treatment[J].Circ Cardiovasc Interv,2015,8(1):e002079.DOI:10.1161/CIRCINTERVENTIONS.114.002079.
• [47]Ten Berg J,Sibbing D,Rocca B,et al.Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation:a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions(EAPCI),in collaboration with the ESC Council on Valvular Heart Disease[J].Eur Heart J,2021,42(23):2265-2269.DOI:10.1093/eurheartj/ehab196.
• [48]Barbanti M,Todaro D,Costa G,et al.Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement[J].Circ Cardiovasc Interv,2017,10(8):e005234.DOI:10.1161/CIRCINTERVENTIONS.117.005234.
• [49]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2025)[J].中华心血管病杂志,2025,53(7):717-745.DOI:10.3760/cmaj.cn112148-20250422-00302.
• [50]Perez S,Thielhelm TP,Cohen MG.To revascularize or not before transcatheter aortic valve implantation?[J].J Thorac Dis,2018,10(Suppl 30):S3578-S3587.DOI:10.21037/jtd.2018.09.85.
• [51] Muratori M,Fusini L,Tamborini G,et al.Sustained favourable haemodynamics 1 year after TAVI:improvement in NYHA functional class related to improvement of leftventricular diastolic function[J].Eur Heart J Cardiovasc Imaging,2016,17(11):1269-1278.DOI:10.1093/ehjci/jev306.
• [52] Tanaka A,Jabbour RJ,Testa L,et al.Incidence,technical safety,and feasibility of coronary angiography and intervention following self-expanding transcatheter aortic valve replacement[J].Cardiovasc Revasc Med,2019,20(5):371-375.DOI:10.1016/j.carrev.2019.01.026.
• [53]Ibrahim H,Chaus A,Alkhalil A,et al.Coronary artery obstruction after transcatheter aortic valve implantation:past,present,and future[J].Circ Cardiovasc Interv,2024,17(6):e012827.DOI:10.1161/CIRCINTERVENTIONS.123.012827.
• [54]Weferling M,Hamm CW,Kim WK.Percutaneous coronary intervention in transcatheter aortic valve implantation patients:overview and practical management[J].Front Cardiovasc Med,2021,8:653768.DOI:10.3389/fcvm.2021.653768.
• [55]Ochiai T,Chakravarty T,Yoon SH,et al.Coronary access after TAVR[J].JACC Cardiovasc Interv,2020,13(6):693-705.DOI:10.1016/j.jcin.2020.01.216.
• [56]Khan M,Senguttuvan NB,Krishnamoorthy P,et al.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement with medtronic self-expanding prosthesis:insights from correlations with computer tomography[J].Int J Cardiol,2020,317:18-24.DOI:10.1016/j.ijcard.2020.05.065.
• [57]Tarantini G,Nai Fovino L,Belloni F,et al.The coronary access after TAVI(CAvEAT)study:a prospective registry of CA after TAVR[J].JACC Cardiovasc Interv,2025,18(12):1571-1583.DOI:10.1016/j.jcin.2025.05.002.
• [58]Khokhar AA,Laricchia A,Ponticelli F,et al.Computed tomography analysis of coronary ostia location following valve-in-valvetranscatheter aortic valve replacement with the ACURATE neo valve:Implications for coronary access[J].Catheter Cardiovasc Interv,2021,98(3):595-604.DOI:10.1002/ccd.29503.
• [59]施浩,万俊义,李琦,等.生物瓣主动脉根部置换术后远期行经导管主动脉瓣“瓣中瓣"置换术的冠状动脉阻塞风险分析[J].中国循环杂志,2023,38(5):508-514.DOI:10.3969/j.issn.1000-3614.2023.05.004.
• [60]Ribeiro HB,Webb JG,Makkar RR,et al.Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry[J].J Am Coll Cardiol,2013,62(17):1552-1562.DOI:10.1016/j.jacc.2013.07.040.
• [61]Ribeiro HB,Rodés-Cabau J,Blanke P,et al.Incidence,predictors,and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves:insights from the VIVID registry[J].Eur Heart J,2018,39(8):687-695.DOI:10.1093/eurheartj/ehx45 5.
• [62]牛冠男,王墨扬,赵庆豪,等.冠状动脉低开口患者行经导管主动脉瓣置换术的结果分析[J].中国循环杂志,2022,37(4):356-361.DOI:10.3969/j.issn.1000-3614.2022.04.007.
• [63]Ribeiro HB,Nombela-Franco L,Urena M,et al.Coronary obstruction following transcatheter aortic valve implantation:a sy stematic review[J].JACC Cardiovasc Interv,2013,6(5):452-461.DOI:10.1016/j.jcin.2012.11.014.
• [64]Ribeiro HB,Rodés-Cabau J,Blanke P,et al.Incidence,predictors,and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative biopro sthetic surgical valves:insights from the VIVID registry[J].Eur Heart J,2018,39(8):687-695.DOI:10.1093/eurheartj/ehx455.
• [65]Mercanti F,Rosseel L,Neylon A,et al.Chimney stenting for coronary occlusion during TAVR:insights from the chimney registry[J].JACC Cardiovasc Interv,2020,13(6):751-761.DOI:10.1016/j.jcin.2020.01.227.
• [66]Sanchez JZ,Burzotta F,Valenzuela T,et al.Direct visualization of TAVR-related coronary artery management techniques in reanimated beating hearts[J].JACC Cardiovasc Interv,2021,14(9):e87-e91.DOI:10.1016/j.jcin.2021.02.045.
• [67]Khan JM,Dvir D,Greenbaum AB,et al.Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement:concept to first-in-human[J].JACC Cardiovasc Interv,2018,11(7):677-689.DOI:10.1016/j.jcin.2018.01.247.
• [68]Dvir D,Leon MB,Abdel-Wahab M,et al.First-in-human dedicated leaflet splitting device for prevention of coronary obstruction in transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2023,16(1):94-102.DOI:10.1016/j.jcin.2022.10.050.
• [69]Phichaphop A,Okada A,Fukui M,et al.Incidence,predictors,and outcomes of unplanned coronary angiography after transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2025,18(2):217-225.DOI:10.1016/j.jcin.2024.07.042.
• [70]de Azevedo Filho AF,Accorsi TA,Ribeiro HB.Coronary artery disease in patients with aortic stenosis and transcatheter aortic valve implantation:implications for management[J].Eur Cardiol,2021,16:e49.DOI:10.15420/ecr.2021.27.
• [71] Gupta T,Zimmer J,Lahoud RN,et al.National trends and outcomes of acute myocardial infarction after transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2024,17(10):1267-1276.DOI:10.1016/j.jcin.2024.02.026.
• [72]Yudi MB,Sharma SK,Tang GHL,et al.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement[J].J Am Coll Cardiol,2018,71(12):1360-1378.DOI:10.1016/j.jacc.2018.01.057.